Table 4.

Variables associated with improvement in clinical status at day 7.

	β Coefficient	95% Confidence interval	p -value
Treatment
SC	Reference	-	0.156
SC + Sarilumab	−0.89	−2.11 – 0.34
Gender
Male	Reference	-	0.085
Female	−1.07	−2.30 – 0.15
Cumulative GC dose (by g of prednisone) a	−1.92	−3.27 to −0.58	0.005

SC, standard care; GC, glucocorticoids; g, gram.

^aCumulative GC dose from randomization to day 7.